Results 171 to 180 of about 22,540 (195)

Anakinra

Reactions Weekly, 2015
  +4 more sources

Anakinra

Reactions Weekly, 2006
openaire   +2 more sources

Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis

Cell Host and Microbe, 2020
Quirijn de Mast, Simone Moorlag, Frank van de Veerdonk   +2 more
exaly  

Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy

International Journal of Molecular Sciences, 2021
Shinichiro Morichi, Gaku Yamanaka, Tomoko Takamatsu   +2 more
exaly  

Off-Label studies on anakinra in dermatology: a review

Journal of Dermatological Treatment, 2022
Jeffrey Zhao, Peter A. Lio, Giancarlo Atassi   +2 more
exaly  

Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study.

European Journal of Preventive Cardiology, 2020
Dimitris Tousoulis, Giacomo Emmi
exaly  

Current evidence on the use of anakinra in COVID-19

International Immunopharmacology, 2022
Fariba Pourkarim, Mohammad Solduzian, Elnaz Khani   +2 more
exaly  

The Effect of Anakinra in Hospitalized Patients with COVID-19: An Updated Systematic Review and Meta-Analysis

Journal of Clinical Medicine, 2021
Konstantinos Kyriakoulis, Anastasios Kollias, Andriani Charpidou   +2 more
exaly  

Effects of anakinra on the small intestine mucositis induced by methotrexate in rats

Experimental Animals, 2020
Murat Cankaya, Emin Murat Akbaş, Renad Mammadov   +2 more
exaly  

A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID-19

Immunity, Inflammation and Disease, 2022
Omid Moradi, Alireza Manafi-rasi, Masoomeh Raoufi   +2 more
exaly